| mRNA |
dacarbazine |
CTRPv2 |
pan-cancer |
AAC |
0.0027 |
0.9 |
| mRNA |
PI-103 |
CTRPv2 |
pan-cancer |
AAC |
0.0028 |
0.9 |
| mRNA |
Sunitinib |
CTRPv2 |
pan-cancer |
AAC |
-0.0027 |
0.9 |
| mRNA |
S-Trityl-L-cysteine |
GDSC1000 |
pan-cancer |
AAC |
0.0039 |
0.9 |
| mRNA |
canertinib |
CTRPv2 |
pan-cancer |
AAC |
0.0027 |
0.9 |
| mRNA |
CMK |
GDSC1000 |
pan-cancer |
AAC |
-0.0037 |
0.9 |
| mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0023 |
0.9 |
| mRNA |
CI-976 |
CTRPv2 |
pan-cancer |
AAC |
0.0026 |
0.9 |
| mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0025 |
0.9 |
| mRNA |
salermide |
CTRPv2 |
pan-cancer |
AAC |
0.003 |
0.9 |